Literature DB >> 22468003

Formulation and characterization of modified release tablets containing isoniazid using swellable polymers.

M F Akhtar1, M Rabbani, A Sharif, B Akhtar, A Saleem, G Murtaza.   

Abstract

The aim of this work was to develop swellable modified release (MR) isoniazid tablets using different combinations of polyvinyl acetate (PVAc) and sodium-carboxymethylcellulose (Na-CMC). Granules were prepared by moist granulation technique and then compressed into tablets. In vitro release studies for 12 hr were carried out in dissolution media of varying pH i.e. pH 1.2, 4.5, 7.0 and 7.5. Tablets of all formulations were found to be of good physical quality with respect to appearance (width and thickness), content uniformity, hardness, weight variation and friability. In vitro release data showed that increasing total polymer content resulted in more retarding effect. Formulation with 35% polymer content exhibited zero order release profile and it released 35% of the drug in first hr, later on, controlled drug release was observed upto the 12(th) hour. Formulations with PVAc to Na-CMC ratio 20:80 exhibited zero order release pattern at levels of studied concentrations, which suggested that this combination can be used to formulate zero order release tablets of water soluble drugs like isoniazid. Korsmeyer-Peppas modeling of drug release showed that non-Fickian transport is the primary mechanism of isoniazid release from PVAc and Na-CMC based tablets. The value of mean dissolution time decreased with the increase in the release rate of drug clearly showing the retarding behavior of the swellable polymers. The application of a mixture of PVAc to Na-CMC in a specific ratio may be feasible to formulate zero order release tablets of water soluble drugs like isoniazid.

Entities:  

Keywords:  Isoniazid; Modified release tablets; Polyvinyl acetate; Sodium-carboxymethylcellulose

Mesh:

Substances:

Year:  2011        PMID: 22468003      PMCID: PMC3252227          DOI: 10.4314/ajtcam.v8i3.65286

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  8 in total

1.  Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.

Authors:  P O'Hara; A J Hickey
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention.

Authors:  C Narendra; M S Srinath; Ganesh Babu
Journal:  AAPS PharmSciTech       Date:  2006-04-07       Impact factor: 3.246

3.  A comparative study of various microencapsulation techniques: effect of polymer viscosity on microcapsule characteristics.

Authors:  Ghulam Murtaza; Mahmood Ahamd; Naveed Akhtar; Fatima Rasool
Journal:  Pak J Pharm Sci       Date:  2009-07       Impact factor: 0.684

Review 4.  Mathematical modeling of drug delivery.

Authors:  J Siepmann; F Siepmann
Journal:  Int J Pharm       Date:  2008-09-11       Impact factor: 5.875

5.  Zero-order drug release from hydrocolloid matrices.

Authors:  J E Möckel; B C Lippold
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

6.  The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis.

Authors:  B Blomberg; S Spinaci; B Fourie; R Laing
Journal:  Bull World Health Organ       Date:  2003-11-05       Impact factor: 9.408

7.  Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.

Authors:  Md Selim Reza; Mohiuddin Abdul Quadir; Syed Shabbir Haider
Journal:  J Pharm Pharm Sci       Date:  2003 May-Aug       Impact factor: 2.327

8.  Regional gastrointestinal permeability of rifampicin and isoniazid (alone and their combination) in the rat.

Authors:  T T Mariappan; S Singh
Journal:  Int J Tuberc Lung Dis       Date:  2003-08       Impact factor: 2.373

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.